Security Snapshot

INTEGRAL AD SCIENCE HOLDING CORP. - Common Stock, $0.001 par value per share (IAS) Institutional Ownership

CUSIP: 45828L108

13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

2

Shares (Excl. Options)

330

Price

$10.17

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
IAS
Shares outstanding
167,832,380
Price per share
$10.34
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
330
Total reported value
$3,412
% of total 13F portfolios
0%
Share change
-162,307,981
Value change
-$1,650,621,947
Number of holders
2
Price from insider filings
$10.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • IAS - INTEGRAL AD SCIENCE HOLDING CORP. - Common Stock, $0.001 par value per share is tracked under CUSIP 45828L108.
  • 2 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 2 to 0 between Q4 2025 and Q1 2026.
  • Reported value moved from $3,412 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 2 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 45828L108?
CUSIP 45828L108 identifies IAS - INTEGRAL AD SCIENCE HOLDING CORP. - Common Stock, $0.001 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of INTEGRAL AD SCIENCE HOLDING CORP. - Common Stock, $0.001 par value per share (IAS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Sunriver Management LLC 4.3% -20% $72,411,997 -$17,317,039 7,120,157 -19% SUNRIVER MANAGEMENT LLC 30 Sep 2025
GLAZER CAPITAL, LLC 4.2% -36% $71,006,577 -$36,818,209 6,981,827 -34% Glazer Capital, LLC 31 Dec 2025

As of 31 Dec 2025, 2 institutional investors reported holding 330 shares of INTEGRAL AD SCIENCE HOLDING CORP. - Common Stock, $0.001 par value per share (IAS). This represents 0% of the company’s total 167,832,380 outstanding shares.

Institutional Holders of INTEGRAL AD SCIENCE HOLDING CORP. - Common Stock, $0.001 par value per share (IAS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 0 $0 -$3,402 $10.34 0
2025 Q4 330 $3,412 -$1,650,621,947 $10.17 2
2025 Q3 162,237,804 $1,649,958,851 +$38,465,309 $10.17 169
2025 Q2 161,302,415 $1,340,413,879 +$21,177,283 $8.31 167
2025 Q1 158,913,957 $1,280,907,870 +$6,183,963 $8.06 183
2024 Q4 157,013,768 $1,639,233,773 +$10,942,383 $10.44 162
2024 Q3 155,253,832 $1,678,301,051 -$7,490,949 $10.81 168
2024 Q2 156,540,646 $1,521,575,056 +$48,941,489 $9.72 153
2024 Q1 151,179,932 $1,507,267,904 -$34,001,193 $9.97 164
2023 Q4 152,051,602 $2,188,098,209 +$24,773,185 $14.39 173
2023 Q3 150,627,018 $1,790,970,912 -$13,700,552 $11.89 163
2023 Q2 150,627,248 $2,708,276,328 +$18,710,371 $17.98 167
2023 Q1 149,864,180 $2,138,488,934 +$29,872,291 $14.27 114
2022 Q4 148,104,635 $1,301,853,690 -$3,576,426 $8.79 105
2022 Q3 148,973,800 $1,079,153,266 -$28,475,728 $7.24 96
2022 Q2 149,824,703 $1,487,805,317 +$6,990,414 $9.93 87
2022 Q1 148,720,656 $2,053,137,371 -$74,182,167 $13.80 87
2021 Q4 153,375,601 $3,406,359,912 +$45,043,910 $22.21 78
2021 Q3 145,093,409 $2,993,365,044 +$23,018,213 $20.63 69
2021 Q2 143,921,089 $2,961,335,000 +$2,961,335,000 $20.58 70
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .